Your browser doesn't support javascript.
loading
Safety and immunogenicity of an AS03-adjuvanted plant-based SARS-CoV-2 vaccine in Adults with and without Comorbidities.
Charland, Nathalie; Gobeil, Philipe; Pillet, Stéphane; Boulay, Iohann; Séguin, Annie; Makarkov, Alexander; Heizer, Gretchen; Bhutada, Kapil; Mahmood, Asif; Trépanier, Sonia; Hager, Karen; Jiang-Wright, Julia; Atkins, Judith; Saxena, Pooja; Cheng, Matthew P; Vinh, Donald C; Boutet, Philippe; Roman, François; Van Der Most, Robbert; Ceregido, Maria Angeles; Dionne, Marc; Tellier, Guy; Gauthier, Jean-Sébastien; Essink, Brandon; Libman, Michael; Haffizulla, Jason; Fréchette, André; D'Aoust, Marc-André; Landry, Nathalie; Ward, Brian J.
Afiliação
  • Charland N; Medicago Inc., 1020 route de l'Église, Bureau 600, Québec, QC, Canada.
  • Gobeil P; Medicago Inc., 1020 route de l'Église, Bureau 600, Québec, QC, Canada.
  • Pillet S; Medicago Inc., 1020 route de l'Église, Bureau 600, Québec, QC, Canada.
  • Boulay I; Medicago Inc., 1020 route de l'Église, Bureau 600, Québec, QC, Canada.
  • Séguin A; Medicago Inc., 1020 route de l'Église, Bureau 600, Québec, QC, Canada.
  • Makarkov A; Medicago Inc., 1020 route de l'Église, Bureau 600, Québec, QC, Canada.
  • Heizer G; Medicago Inc., 1020 route de l'Église, Bureau 600, Québec, QC, Canada.
  • Bhutada K; Medicago Inc., 1020 route de l'Église, Bureau 600, Québec, QC, Canada.
  • Mahmood A; Medicago Inc., 1020 route de l'Église, Bureau 600, Québec, QC, Canada.
  • Trépanier S; Medicago Inc., 1020 route de l'Église, Bureau 600, Québec, QC, Canada.
  • Hager K; Medicago Inc., 1020 route de l'Église, Bureau 600, Québec, QC, Canada.
  • Jiang-Wright J; Vertex Pharmaceticals, 50 Northern Avenue, Boston, MA, USA.
  • Atkins J; Medicago Inc., 1020 route de l'Église, Bureau 600, Québec, QC, Canada.
  • Saxena P; Medicago Inc., 1020 route de l'Église, Bureau 600, Québec, QC, Canada.
  • Cheng MP; Medicago Inc., 1020 route de l'Église, Bureau 600, Québec, QC, Canada.
  • Vinh DC; Research Institute of the McGill University Health Centre, 1001 Decarie St, Montréal, QC, Canada.
  • Boutet P; Research Institute of the McGill University Health Centre, 1001 Decarie St, Montréal, QC, Canada.
  • Roman F; GSK, Wavre, Belgium.
  • Van Der Most R; GSK, Wavre, Belgium.
  • Ceregido MA; GSK, Wavre, Belgium.
  • Dionne M; BioNTech SE, An der Goldgrube 12, Mainz, Germany.
  • Tellier G; GSK, Wavre, Belgium.
  • Gauthier JS; CHU de Québec-Université Laval, 2400 d'Estimauville, Québec City, QC, Canada.
  • Essink B; Manna Research, 101-13714 Boul Du Curé-Labelle, Suite 101, Mirabel, QC, Canada.
  • Libman M; Q&T Research Sherbrooke Inc., 2185 King Street West, Suite 101, Sherbrooke, QC, Canada.
  • Haffizulla J; Meridian Clinical Research, 3319 N 107th St, Omaha, NE, USA.
  • Fréchette A; Research Institute of the McGill University Health Centre, 1001 Decarie St, Montréal, QC, Canada.
  • D'Aoust MA; Precision Clinical Research, 8399 West Oakland Park Blvd., Suite B & C, Sunrise, FL, USA.
  • Landry N; Diex Research Québec Inc., 205 rue Montmagny, Suite 103, Québec City, QC, Canada.
  • Ward BJ; Medicago Inc., 1020 route de l'Église, Bureau 600, Québec, QC, Canada.
NPJ Vaccines ; 7(1): 142, 2022 Nov 09.
Article em En | MEDLINE | ID: mdl-36351931
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: NPJ Vaccines Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: NPJ Vaccines Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Canadá